Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Voluntary License Scorecard
Update on I-MAK’s patent observations against Abbott Laboratories in Europe
Tahir Amin Speaks at the International AIDS Conference 2012
India’s Supreme Court to Hear Dispute on Drug Patents
Do Not Push: A Patent Rebellion
Implications of the Patent Pool Licenses With Gilead (Part II)
Cheap Drugs Pulled Despite Wealth Gap in Middle Income Countries
Trans-Pacific Trade Agreement: GPhA, NGOs Oppose Proposed IP Provisions
Implications of the Patent Pool Licenses with Gilead
Trans-Pacific Partnership Agreement: Did U.S. Move Threaten Public Health?